Elena Medo is the CEO of Medolac Laboratories, a public benefit corporation which she co-founded with Adrianne Weir. Medo has dedicated her career to improving outcomes for preterm infants by using technology to increase access to lifesaving human milk.
Medolac offers the first ready to feed, sterile, shelf stable human milk that can be shipped and stored at room temperature. Medo has raised over $35M for her last three life science startups, using disruptive innovation to achieve the goal of feeding the world’s 15 million preterm infants born each year.
She holds numerous patents and her contributions to the space prior to Medolac include the development of the double breast pumping system, the first online milk bank, the first customized formulation of human milk to treat preterm infants and the first midrange IR human milk analyzer.
Her innovative collaboration with co-founder and daughter, Adrianne Weir led to a massive redesign of the milk banking business model, including the founding of the Mother’s Milk Cooperative enabling healthy nursing mothers to transact the sale of surplus milk in a safe and secure environment. The mission of the Company is to make human milk available to all babies in need, regardless of their economic status.
Medo has an MBA from the Paul Merage School of Business at the University of California, Irvine where she also studied Computer Science and Developmental and Cell Biology as an Undergraduate.
Adrianne co-founded Medolac in 2009 with her serial entrepreneur mother, Elena Medo, after she spent more than a decade in healthcare. Having previously developed a national network of human milk banks, Adrianne has strong market instincts with a focus on innovations that have a global market reach. She is driven to improve access and expand use of lifesaving human milk products. This mother-daughter duo are the innovation leaders for neonatal nutrition, and the global human milk market. Medolac has developed a pipeline of innovative human milk based products to serve a potential $1B domestic market.
Adrianne’s leadership has helped defined Medolac as a company of firsts:
• The only female led commercial milk bank in the world
• First application of high volume food processing and economies of scale to human milk
• The only shelf-stable (non-frozen) human milk products
Medolac has made it possible to deliver human milk anywhere – from the hospital NICU to home, to critical humanitarian needs. Adrianne’s contributions continue to disrupt this space with exciting innovations around purified components for nutritional, therapeutic and research applications. Her leadership and innovation has created significant advances for Medolac and its mission to deliver lifesaving human milk to infants around the world.
Marie Boone-ClarkVICE PRESIDENT OF SALES AND EXTERNAL RELATIONS
Marie’s commitment to infant nutrition is obvious from her long career at Mead Johnson where she held many positions in sales, consumer marketing, and professional affairs. While with Mead Johnson, she created Communis Doctrina (Latin for “shared learning”), a medical journal discussion group that explored contemporary topics in neonatology to facilitate discussion across three major medical schools.
Marie is a graduate of the University of Evansville. She serves on the Board of Director’s for Graham’s Foundation, a national nonprofit devoted to supporting the parents of premature infants. Marie is also a non-physician member of the National Medical Association, where she works closely with the Pediatrics and Executive Physicians sections.
A Kentucky native, Marie currently resides in Scottsdale, Arizona. She enjoys visual art, gardening and traveling.
Donald H. ChaceCHIEF SCIENTIFIC OFFICER
Donald H. Chace, PhD, MSFS, FACB is the Chief Scientific Officer for Medolac. He is one of the primary developers of newborn metabolic screening using tandem mass spectrometry. Dr. Chace is an expert in metabolism and clinical chemistry using mass spectrometry and dried blood spot analysis. Millions of newborns are screened annually for inherited genetic disease using his patented methods. He has published nearly 100 peer reviewed articles and has presented at numerous conferences on a range of subjects including, neonatology, clinical chemistry, newborn screening, mass spectrometry and forensic science. He is currently working on validating the benefits of human breast milk in improving the growth of premature infants. In addition, he is developing both analytical and bioinformatic tools to aid the neonatologist in delivering more personalized, nutritional care to the premature infant. Dr. Chace received his BS in chemistry from Boston College. His graduate degrees include a Masters in Science in Forensic Science with specialty in Forensic Toxicology and a PhD in Pharmacology. Both degrees earned from The George Washington University in Washington DC.
Pamela MoffatCHIEF MARKETING OFFICER
Prior to joining Medolac, Pamela worked at top creative agencies in NY and LA where her clients were Fortune 500 companies, healthcare non-profits and bio-tech start-ups. As a communication and branding expert, Pamela has helped shape some of the world’s most admired brands including GE, Unilever, Mars, and TAGHeuer.
With a unique combination of experience, insight, intuition and heart, she has helped transform brands, achieve outstanding growth, and create award-winning campaigns.
Pamela was drawn to Medolac because of their innovative approach to the market, the strength of their team and their commitment to making a difference in the world.
She has served on the boards of an international peace organization, a progressive school and non-profit for female entrepreneurs.
“What lies behind us and what lies ahead of us are tiny matters compared to what lies within us.”